The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of
PF-06473871 in normal healthy adults.
- Healthy male and/or females between the ages of 18 and 55 years inclusive
- Currently pregnant
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: